Check-Cap Ltd. Ordinary Share (MBAI) Stock

Check-Cap Ltd. Ordinary Share (MBAI) is a Healthcare stock trading at $1.41 (as of 2026-06-18), with a market capitalization of $10.36M and a trailing P/E of 2.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Check-Cap Ltd. is a clinical-stage medical diagnostics company focused on capsule-based screening technology products. Incorporated in 2004 and based in Isfiya, Israel, it develops diagnostic approaches using its capsule screening platform.

Valuation — source: SEC EDGAR (first-party)
Price$1.41
Market Cap$10.36M
P/E Ratio2.2
EV / EBITDA-4.2
Price / Book2.92
Price / Sales58.37
DCF Value (model)$-0.11
DCF Upside vs Price-107.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$172000.00
Net Margin2407.0%
Return on Equity120.5%
Current Ratio0.05
Revenue Growth (YoY)-78.7%
EPS Growth (YoY)-84.7%
Financial Health — source: SEC EDGAR
Altman Z-Score-31.19 (distress)
Valuation vs Sector & Industry
Stock P/E2.2
Sector P/E (Healthcare)20.9
Industry P/E (Medical Equipment)31.7
vs Sector-89.6%
vs Industry-93.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderUBS Group AG ($36631.00)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEODavid Lontini
CountryIL
IPO Date2015-03-04

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Adagio Medical Holdings, Inc. (ADGM)
  • Milestone Scientific Inc. (MLSS)
  • IRIDEX Corporation (IRIX)
  • Bionano Genomics, Inc. (BNGO)
  • Sintx Technologies, Inc. (SINT)
  • Polyrizon Ltd. (PLRZ)
  • Intelligent Bio Solutions Inc. (INBS)
  • Astrotech Corporation (ASTC)
MBAI earnings history · MBAI institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.